Individual analysis of patients with HoFH participating in a phase 3 trial with lomitapide: The Italian cohort.
Nutr Metab Cardiovasc Dis
; 26(1): 36-44, 2016 Jan.
Article
in En
| MEDLINE
| ID: mdl-26723464
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Benzimidazoles
/
Receptors, LDL
/
Heterozygote
/
Hyperlipoproteinemia Type II
/
Anticholesteremic Agents
/
Mutation
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Guideline
/
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Nutr Metab Cardiovasc Dis
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
/
CIENCIAS DA NUTRICAO
/
METABOLISMO
Year:
2016
Document type:
Article
Country of publication:
Netherlands